We evaluated eIF4B and BACE1 levels by western blot and immunohistochemistry in brains of APPPS1 mice [56] at two time points: 2 months, representative of a stage with scarce pathology and 6 months, representing fully established AD pathology. This evidence concerns the gene BACE1 and Alzheimer disease.